Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anusha Thomas

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
American Journal of Clinical Oncology|February 3, 2023
Characteristics and Outcomes of Cancer Patients With Venous Thromboembolic Events After Treatment With Immune Checkpoint InhibitorsBarbara Dutra, Victor Garcia-Rodriguez, Rogelio Garcia, et al.
Journal of Cancer Research and Clinical Oncology|September 27, 2022
Characteristics of appendicitis after immune checkpoint inhibitor therapy among cancer patientsAntony Mathew, Malek Shatila, Zongshan Lai, et al.
American Journal of Clinical Oncology|May 23, 2023
Impact of Selective Immunosuppressive Therapy on Subsequent Immune-Related Adverse Events After Immune Checkpoint Inhibitor-Induced Colitis TreatmentAntonio Pizuorno Machado, Malek Shatila, Isabella C Glitza Oliva, et al.
Journal of Cancer Research and Clinical Oncology|January 7, 2023
Characteristics, treatment, and outcome of patients with bowel perforation after immune checkpoint inhibitor exposureAntonio Pizuorno Machado, Malek Shatila, Cynthia Liu, et al.
Targeted Oncology|February 4, 2025
Checkpoint Inhibition Prior to Stem Cell Transplantation Increases the Risk of Inflammatory Adverse EventsMalek Shatila, Antonio Pizuorno Machado, Jay Shah, et al.
Cureus|September 12, 2024
Outcomes of Different Surgical Interventions for Treating Trigeminal Neuralgia: A ReviewBilly McBenedict, Wilhelmina N Hauwanga, Melvin Chun Yang Yau, et al.
Cureus|July 4, 2024
Neuropathic Pain Secondary to Multiple Sclerosis: A Narrative ReviewBilly McBenedict, Kang Suen Goh, Ryan Chun Chien Yau, et al.
Journal of Cancer Research and Clinical Oncology|July 5, 2024
Gastrointestinal toxicities of proteasome inhibitor therapyJay Shah, Samanthika Devalaraju, Elliot Baerman, et al.
Cureus|December 2, 2024
Magnetic Resonance Imaging Features for Distinguishing High-Grade From Low-Grade Soft Tissue Sarcoma: A Systematic Review and Meta-AnalysisWilhelmina N Hauwanga, Billy McBenedict, Kang Suen Goh, et al.
Annals of Gastroenterology|March 23, 2026
Isolated immune-mediated enteritis in patients treated with immune checkpoint inhibitor therapySharada Wali, Rohan Srinivas Patel, Maria Julia Moura Nascimento Santos, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
American Journal of Clinical Oncology|February 3, 2023
Characteristics and Outcomes of Cancer Patients With Venous Thromboembolic Events After Treatment With Immune Checkpoint InhibitorsBarbara Dutra, Victor Garcia-Rodriguez, Rogelio Garcia, et al.
Journal of Cancer Research and Clinical Oncology|September 27, 2022
Characteristics of appendicitis after immune checkpoint inhibitor therapy among cancer patientsAntony Mathew, Malek Shatila, Zongshan Lai, et al.
American Journal of Clinical Oncology|May 23, 2023
Impact of Selective Immunosuppressive Therapy on Subsequent Immune-Related Adverse Events After Immune Checkpoint Inhibitor-Induced Colitis TreatmentAntonio Pizuorno Machado, Malek Shatila, Isabella C Glitza Oliva, et al.
Journal of Cancer Research and Clinical Oncology|January 7, 2023
Characteristics, treatment, and outcome of patients with bowel perforation after immune checkpoint inhibitor exposureAntonio Pizuorno Machado, Malek Shatila, Cynthia Liu, et al.
Targeted Oncology|February 4, 2025
Checkpoint Inhibition Prior to Stem Cell Transplantation Increases the Risk of Inflammatory Adverse EventsMalek Shatila, Antonio Pizuorno Machado, Jay Shah, et al.
Cureus|September 12, 2024
Outcomes of Different Surgical Interventions for Treating Trigeminal Neuralgia: A ReviewBilly McBenedict, Wilhelmina N Hauwanga, Melvin Chun Yang Yau, et al.
Cureus|July 4, 2024
Neuropathic Pain Secondary to Multiple Sclerosis: A Narrative ReviewBilly McBenedict, Kang Suen Goh, Ryan Chun Chien Yau, et al.
Journal of Cancer Research and Clinical Oncology|July 5, 2024
Gastrointestinal toxicities of proteasome inhibitor therapyJay Shah, Samanthika Devalaraju, Elliot Baerman, et al.
Cureus|December 2, 2024
Magnetic Resonance Imaging Features for Distinguishing High-Grade From Low-Grade Soft Tissue Sarcoma: A Systematic Review and Meta-AnalysisWilhelmina N Hauwanga, Billy McBenedict, Kang Suen Goh, et al.
Annals of Gastroenterology|March 23, 2026
Isolated immune-mediated enteritis in patients treated with immune checkpoint inhibitor therapySharada Wali, Rohan Srinivas Patel, Maria Julia Moura Nascimento Santos, et al.
Pageof 3